spiperone has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 3 studies
Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
spiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Eight patients with pituitary adenoma including four non-functioning adenomas, two growth hormone (GH) secreting adenomas, one ACTH secreting adenoma and one TSH secreting adenoma and ten normal healthy volunteers were examined." | 1.29 | [Clinical application of 11C-NMSP to the patients with pituitary adenoma other than prolactinoma]. ( Inoue, Y; Momose, T; Nishikawa, J; Sasaki, Y; Teramoto, A; Watanabe, T, 1993) |
"In cultures of prolactinoma cells from patients normally responsive to bromocriptine therapy (n = 10), considered as controls, 10(-9) mol/L bromocriptine inhibited PRL release by 71 +/- 6% (+/- SE), and the half-inhibitory dose was 7 x 10(-11) mol/L." | 1.28 | Resistance to bromocriptine in prolactinomas. ( Bertrand, P; Delivet, S; Enjalbert, A; Gunz, G; Jaquet, P; Jedynak, CP; Kordon, C; Peillon, F; Pellegrini, I; Rasolonjanahary, R, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Momose, T | 1 |
Teramoto, A | 1 |
Nishikawa, J | 1 |
Inoue, Y | 1 |
Watanabe, T | 1 |
Sasaki, Y | 1 |
McChesney, R | 1 |
Sealfon, SC | 1 |
Tsutsumi, M | 1 |
Dong, KW | 1 |
Roberts, JL | 1 |
Bancroft, C | 1 |
Pellegrini, I | 1 |
Rasolonjanahary, R | 1 |
Gunz, G | 1 |
Bertrand, P | 1 |
Delivet, S | 1 |
Jedynak, CP | 1 |
Kordon, C | 1 |
Peillon, F | 1 |
Jaquet, P | 1 |
Enjalbert, A | 1 |
3 other studies available for spiperone and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
[Clinical application of 11C-NMSP to the patients with pituitary adenoma other than prolactinoma].
Topics: Adenoma; Adult; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolac | 1993 |
Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter.
Topics: Animals; Cell Line; Ergolines; Female; Hysterectomy; Ovariectomy; Pituitary Neoplasms; Plasmids; Pro | 1991 |
Resistance to bromocriptine in prolactinomas.
Topics: 17-Hydroxycorticosteroids; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adolescent; Adult; Bromoc | 1989 |